ANTALYRE, eye drop solution in a single-dose container 10 single-dose containers of 0.4 ml
Active ingredients: Salicylic acid
Commercialized according to BDPM
Eye drop solution10 single-dose containers of 0.4 mlophtalmique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ANTALYRE, collyre en solution en récipient unidose
- Pharmaceutical form
- collyre en solution
- Route of administration
- ophtalmique
- Presentation description
- 10 récipient(s) unidose(s) polyéthylène basse densité (PEBD) de 0,4 ml
- Marketing authorisation holder
- EUROPHTA
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 28 Jul 2023
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68082438CIP73641745CIP133400936417458Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ACIDE SALICYLIQUEcollyre | 0,4 mg · 0,4 ml de collyre | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.